Corline Biomedical AB

Renal transplantation

Corline Biomedical AB focuses on clinical research in kidney transplantation, particularly in recipients of deceased-donor grafts. The funded studies examine kidney graft function in patients receiving transplanted kidneys under conditions associated with impaired early graft performance.

  • Deceased-donor kidney transplantation
  • Graft function
  • Delayed graft function

The company’s active trial portfolio is centered on transplant outcomes in settings where preservation of renal viability is clinically important.

Ischemia-reperfusion injury

Another key area of interest is ischemia-reperfusion injury in the transplanted kidney, with attention to patients at elevated risk of early post-transplant complications. This work is closely linked to the prevention of tissue damage affecting renal recovery after transplantation.

  • Renal ischemia-reperfusion injury
  • Early graft impairment
  • Post-transplant renal recovery

These studies place emphasis on preserving organ performance during the critical period following transplantation.

End-stage renal disease

The sponsor’s research is relevant to patients with end-stage renal disease or otherwise severely reduced kidney function, reflecting a therapeutic interest in advanced renal failure and its surgical treatment. The clinical focus remains on improving outcomes for individuals requiring renal replacement through transplantation.

  • Severe kidney dysfunction
  • Renal replacement therapy
  • Transplant recipient care

The funded trials are aligned with the clinical needs of patients whose kidney disease has progressed to the point of transplantation.

Organ preservation

Corline Biomedical AB also shows interest in organ preservation and the condition of donor kidneys before implantation, including kidneys from DBD-ECD and DCD donors. This area is tied to maintaining graft quality from procurement through transplantation.

  • Deceased donor organ preservation
  • Kidney preservation
  • Transplant graft quality

The clinical scope includes donor-organ conditions that influence the likelihood of successful renal graft performance.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials